Product correctly added to cart.

discount label
1-Methyl-1H-indazole-3-carboxamide
View 3D

Biosynth logo

1-Methyl-1H-indazole-3-carboxamide

CAS: 129137-93-5

Ref. 3D-EFA13793

50mg
221.00 €
500mg
881.00 €
Estimated delivery in United States, on Thursday 20 Feb 2025

Product Information

Name:
1-Methyl-1H-indazole-3-carboxamide
Controlled Product
Description:

1-Methyl-1H-indazole-3-carboxamide belongs to the group of indazole derivatives. It is a potent inhibitor of HIV replication and is used as an antiretroviral drug. 1-Methyl-1H-indazole-3-carboxamide has been shown to have antiviral activity against different types of viruses, such as hepatitis B virus, herpes simplex virus type 1, and human cytomegalovirus. The mechanism of action for this drug is not fully understood; however, it may inhibit viral protein synthesis by acting at the level of the polymerase chain reaction. This drug also has a number of side effects on the mother and infant, including metabolic disorders in both, increased body mass index in infants, and increased maternal mortality rates for women with HIV infection.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
175.19 g/mol
Formula:
C9H9N3O
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-EFA13793 1-Methyl-1H-indazole-3-carboxamide

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".